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Accurate assessment of the degree of liver fibrosis is important for estimating prognosis and 
deciding on an appropriate course of treatment for cases of chronic liver disease (CLD) with 
various etiologies. Because of the inherent limitations of liver biopsy, there is a great need for non-
invasive and reliable tests that accurately estimate the degree of liver fibrosis. Ultrasound (US) 
elastography is considered a non-invasive, convenient, and precise technique to grade the degree 
of liver fibrosis by measuring liver stiffness. There are several commercial types of US elastography 
currently in use, namely, transient elastography, acoustic radiation force impulse imaging, 
supersonic shear-wave imaging, and real-time tissue elastography. Although the low reproducibility 
of measurements derived from operator-dependent performance remains a significant limitation 
of US elastography, this technique is nevertheless useful for diagnosing hepatic fibrosis in patients 
with CLD. Likewise, US elastography may also be used as a convenient surveillance method that 
can be performed by physicians at the patients’ bedside to enable the estimation of the prognosis 
of patients with fatal complications related to CLD in a non-invasive manner.
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Introduction
Chronic liver disease (CLD) has various etiologies, with the viral infection of hepatitis B virus (HBV), 
hepatitis C virus (HCV), human immunodeficiency virus, alcohol consumption, hepatotoxic drug 
ingestion, non-alcoholic fatty liver, autoimmune diseases, and cryptogenic hepatopathy being 
commonly encountered in daily practice. Histologically, liver fibrosis develops and gradually progresses 
as a result of following a wound-healing response in patients with CLD. In particular, activation 
of cellular elements including myofibroblasts and stellate cells results in collagen deposition and 
subsequent development of CLD [1,2].
Liver biopsy is known as the gold standard for diagnosing liver fibrosis. However, liver biopsy 
also has considerable limitations. The very small size of samples obtained through biopsy may not 
represent a heterogeneous distribution of liver fibrosis due to sampling bias [3]. In addition, the Woo Kyoung Jeong, et al.
150   Ultrasonography 33(3), July 2014  e-ultrasonography.org
issue of intra- or inter-observer variability among pathologists in 
evaluating the grade of fibrosis is an additional limitation because 
the interpretation process is a subjective and semi-quantified 
method [4]. According to previous research on chronic hepatitis C, 
agreement among pathologists regarding the fibrosis grade is not 
excellent (κ , about 0.5) [5]. Although the rate of complications is 
very low and the risk has declined with the use of ultrasonographic 
guidance [6], liver biopsy is somewhat invasive and post-biopsy 
bleeding can be serious. With respect to non-invasive alternatives 
to liver biopsy, several serological or biochemical methods for the 
estimation of liver fibrosis have been validated primarily in patients 
with chronic hepatitis C, but still lack the ability to identify and 
classify the intermediate stages of fibrosis [7].
Introduced in 1991, elastography is another non-invasive 
technique for evaluating the elastic properties of soft tissue either 
quantitatively or qualitatively [8]. The elastography of the liver is 
theoretically not easy to determine compared with that of superficial 
organs because the liver is located deep and under the rib cage. 
Nevertheless, various techniques of ultrasound (US) elastography 
have been developed for repeatedly measuring hepatic fibrosis. 
From a technical standpoint, two types of US elastography for the 
measurement of liver stiffness are under development: shear wave-
based elastography and real-time tissue elastography (Fig. 1, Table 
1). This review addresses the principles and clinical usefulness of US 
elastography for the diffuse liver disease with an emphasis on shear 
wave-based elastography.
Basic Principles of Elastography
Elastography is a promising imaging technique because the elastic 
modulus of tissues measured by this technique provides the most 
broad-banded properties compared with other quantitative values 
measured by computed tomography (attenuation value), magnetic 
resonance (MR) imaging (T1 relaxation time), and conventional 
ultrasonography (bulk modulus). The order of magnitude of the 
elastic modulus is approximately five times larger than that for 
other imaging modalities [9], meaning that the use of the elastic 
modulus can maximize the discrimination between different tissues 
or between normal tissue and lesions. The elastic modulus is defined 
as the slope of the stress-strain curve during elastic deformation. 
Therefore, a stiffer object has a higher elastic modulus. There are 
various approaches to elastic imaging, all of which consist of three 
basic steps: excitation (stress) application, tissue response (strain) 
measurement, and mechanical parameters estimation [9].
Excitation Application
In its most basic form, shear wave-based elastography applies a 
perpendicular stress force on the target organ to induce “shear” 
on the tissue (Fig. 2). By definition, shear is the change of shape 
(displacement)-without a change in volume-produced by a pair 
of forces acting in opposite directions. At this point, transversely 
propagating waves with a very low velocity develop in the tissue, 
Table 1. Comparison of various techniques of ultrasound elastography
Technique Transient elastography ARFI imaging
Supersonic shear-wave 
imaging
Real-time tissue 
elastography
Type of force Dynamic Dynamic Dynamic Quasi-static
Applied force Mechanical impulse US-induced radiation force 
impulse
US-induced radiation force 
impulse
Intrinsic (heartbeat)
Measurement of strain Single measure, beam-line 
average
Single image within a box Image within a color box Full area image 
Estimated parameter Elastic modulus converted from 
shear wave velocity (kPa)
Velocity of shear wave (cm/sec) Elastic modulus converted from 
shear wave velocity (kPa)
Strain ratio 
Qualitative or quantitative Quantitative  Qualitative/quantitative  Quantitative Qualitative
Clinical evidence Very much Much Little Scanty
ARFI, acoustic radiation force impulse.
Modified from Bamber et al. [54] with permission from Elsevier.
Fig. 1. Classification of ultrasound elastography of the liver. ARFI, 
acoustic radiation force impulse.
Shear wave-based
elastography
Mechanical
push
Transient
elastography
ARFI
imaging
Supersonic shear-
wave imaging
Focused acoustic
beams
Real-time tissue
elastographyUS elastography for diffuse liver disease
e-ultrasonography.org  Ultrasonography 33(3), July 2014 151
which are called shear waves. In the case of transient elastography, 
a mechanical push is used for excitation application, which produces 
transient shear waves in the target tissue. This type of excitation 
application is classified as a dynamic elastography technique 
with an external source. In addition, dynamic techniques induce 
vibrations and comprise the basic method for shear wave-based 
US elastography and MR elastography. In particular, rather than a 
mechanical push with transient elastography, focused US beams 
from a US transducer make shear waves through the absorption 
of acoustic energy; acoustic radiation force impulse (ARFI) imaging 
and supersonic shear-wave imaging (SSI) belong to this category 
[10]. With respect to shear wave elastography (Supersonic Imagine, 
Aix-en-Provence, France), a type of SSI, multiple acoustic radiation 
forces are successively focused at different depths in a tissue to 
generate a strong shear wave to propagate along the tissue at a 
safe level of acoustic power, which is then coherently summed in a 
Mach cone shape and improves the propagation distance [11]. On 
the other hand, real-time tissue elastography methods are derived 
from the static elastography technique used for the measurement of 
breast tissue elasticity, and employ the quasi-static or intrinsic stress 
derived from heartbeats [12,13].
Tissue Response Measurement
Measurement of tissue response is the most critical component 
of elastography. The basic measurement method consists of a 
comparison of successively obtained images and a reference image 
(Fig. 2). Through either a mechanical push or acoustic radiation 
force, the A-axis (direction of force=depth direction) displacement 
of the target tissue occurs, and the shear waves are generated 
simultaneously. These are very slow (1-10 m/sec) compared with 
an US beam and travel perpendicular to the direction of the stress 
force. To detect a shear wave, two methods using US have been 
introduced. Transient elastography causes a single transient shear 
wave to propagate along the A-axis direction by using an M-mode 
US technique and calculates Young modulus of the tissue by using 
this information [14]. Another method is the Doppler technique, 
in which radiofrequency (RF) images including the information 
of the propagating shear waves are measured using the echo of 
the transmitted US beams at a very high frame rate, which can be 
used to generate a tissue displacement map [8,15,16]. Using the 
tissue displacement maps obtained during the period of shear wave 
propagation (i.e., less than 14 ms), it is possible to calculate the 
velocity of a shear wave by analyzing the movement of the peak of 
the shear wave. In this way, the elastic modulus can be calculated 
by E=3 ρ Vs
2 where ρ  denotes the density of the tissue and Vs 
represents the velocity of the shear wave.
Mechanical Parameter Estimation
Both qualitative and quantitative methods are used to perform 
mechanical parameter estimation (Fig. 2). Liver stiffness is usually 
Fig. 2. Diagram depicting the process of shear wave-based ultrasound elastography. Shear wave-based elastography applies a 
perpendicular stress force to a target organ in order to induce shear on the tissue. The information on the propagating shear wave including 
the velocity of the shear wave could be measured by obtaining radiofrequency images with a high frame rate, which can be used to generate 
a tissue displacement map. Then, the elastic property for quantitative estimation is calculated by the propagating velocity of the shear wave. 
ARFI, acoustic radiation force impulse.
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measured quantitatively. The elastic properties for quantitative 
estimation are expressed as Young modulus (E) or the shear 
modulus (μ). For most soft tissues, Young modulus and the shear 
modulus are related by a simple scale factor of 3: i.e., E=3 μ [9]. 
Transient elastography and SSI display tissue stiffness as the elastic 
modulus (kPa), while ARFI imaging shows it by shear wave velocity 
(cm/sec). In the case of real-time elastography, tissue elasticity 
cannot be measured directly from the reflected US echo. Relative 
tissue elasticity is thus calculated and displayed as a color overlay of 
the conventional B-mode image, and the strain ratio between two 
different points can be obtained instead of elastic modulus or shear 
wave velocity.
Methods of Shear Wave-based Elastography
Transient Elastography
Transient elastography was the first commercialized elastography 
method developed to noninvasively assess the stiffness of deep 
soft tissues such as the liver. Transient elastography consists of two 
parts: a mechanical vibrator and a single-channel US transducer 
[14]. The mechanical vibrator generates a low-frequency wave 
at 50-500 Hz to generate shear stress in the target tissue at a 
length of 4 cm, and the velocity of the shear wave can then be 
measured using an US signal (Fig. 3). The most superior advantage 
of transient elastography is that it has been extensively validated 
by numerous investigations targeted at patients with CLD, and the 
results of transient elastography are generally accepted to be well 
correlated with different stages of liver fibrosis. The validity of liver 
stiffness measurements are determined by the success rate and the 
interquartile range divided by the median (IQR/M) in cases with 
more than 10 valid measurements. Here, the success rate is the 
ratio of the number of valid measurements to the total number of 
measurements and should be greater than 60%; IQR/M should be 
lower than 30% [17]. Despite these advantages, there are several 
disadvantages of transient elastography. They are as follows: first, 
transient elastography does not provide a B-mode image, which 
is essential for accurate targeting. Second, transient elastography 
is not performed for the patient with ascites. In addition, transient 
elastography exhibits a relatively high measurement failure rate 
of 4.5%-6%. Major factors related to this failure rate include a 
body mass index greater than 28, age over 50 years, non-alcoholic 
steatohepatitis, diabetes, and a γ -glutamyl-transpeptidase level 
higher than 57 IU/L [18].
Acoustic Radiation Force Impulse Imaging and Shear Wave 
Imaging
Both ARFI imaging and SSI use focused high-intensity, short-
duration acoustic pulses instead of the mechanical vibration of 
transient elastography in order to produce shear waves in the 
target tissue [19]. ARFI imaging generates shear waves by a single 
pushing beam, while shear wave propagation is monitored using 
conventional pulse-echo US at multiple off-axis lateral locations. By 
collecting displacement through time information at multiple lateral 
locations separated by a known distance from the excitation source, 
the speed of the propagating shear waves can be estimated (Fig. 4). 
The region of interest (ROI) of ARFI imaging is relatively small (i.e., 
Fig. 3. Transient elastography of a normal and a cirrhotic patient. 
The displacement M-mode image located in the center of the monitor shows axial displacement as a function of depth (y-axis) and time 
(x-axis). In the healthy patient (A), the shear wave is relatively slow and the liver stiffness is low. However, in the patient with cirrhosis (B), 
the shear wave can propagate more rapidly though a hard tissue, and the time-depth gradient is very steep. The controlled attenuation 
parameter is displayed, which is known to correlate with the fatty liver severity (Courtesy of Dr. Yong Han Paik, Department of Internal 
Medicine, Samsung Medical Center, Seoul, Korea). 
A BUS elastography for diffuse liver disease
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10 mm × 5 mm) as compared to that of SSI. 
SSI is a new shear wave-based US elastography technique. SSI 
generates push beams at multiple axial depths to create a near-
supersonic plane wave shear and transmits the unfocused beam 
(plane wave) to monitor the shear wave propagation throughout 
the ROI (Fig. 5). The ROI of SSI is fan-shaped and larger than other 
modalities (up to 50 mm × 50 mm) [20,21]. A remarkable feature 
of SSI is that it can show viscoelastic properties in all areas in an 
ROI with a color look-up table and thus, is expected to overcome 
the limitations of transient elastography by which liver stiffness 
cannot be measured accurately in patients with severe obesity, thick 
subcutaneous fat, and ascites [22]. Moreover, the same technique 
can be used to display a grayscale US image on the background of 
the elastogram, so it is more reliable and familiar to a physician who 
uses conventional ultrasonography. However, for as wide a use of SSI 
for the diagnosis of liver fibrosis as that of transient elastography, 
further clinical experiences and evidence are needed. 
Real-Time Tissue Elastography
As mentioned above, real-time elastography is a method derived 
from the static elastography technique used for the measurement 
of breast tissue elasticity. Real-time tissue elastography uses 
a grayscale US machine, incorporating elastography into the 
conventional US scanner. This approach uses a quasi-static method 
Fig. 4. Acoustic radiation force impulse imaging of a normal and a cirrhotic patient. 
The cylindrical region of interest (ROI) in the middle of the ultrasonogram was used as the sample volume for the measurement of stiffness. 
Instead of Young modulus, the propagating velocity of the shear wave is displayed. Although the grayscale ultrasonograms are similar to 
each other, the propagating velocity is different: 1.2 m/sec in the healthy patient (A) and 1.6 m/sec in the patient with cirrhosis (B) (Courtesy 
of Dr. Yong Eun Chung, Department of Radiology, Severance Hospital, Seoul, Korea).
A B
Fig. 5. Supersonic shear-wave imaging of a normal and a cirrhotic patient. 
A large trapezoidal color box display of the distribution of the elastic properties of the liver. The severity of stiffness is depicted with the 
colored look-up table. Dark blue color represents normal liver tissue (A), and bright blue-green color represents increased liver stiffness such 
as liver cirrhosis (B). The round region of interest (ROI) in the color box is the Q-Box and the mean Young modulus and standard deviation in 
the ROI have been calculated.
A BWoo Kyoung Jeong, et al.
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analysis of 40 eligible studies showed that the summary sensitivity 
and specificity were 78% and 80% for significant fibrosis, and 83% 
and 90% for cirrhosis, respectively (Table 2). In addition, this meta-
analysis suggested that transient elastography could be used as a 
good screening test for cirrhosis, but not for accurately diagnosing 
fibrotic stages other than cirrhosis because no optimal cut-offs of liver 
stiffness for individual fibrosis stages have been validated. There are 
relatively fewer clinical studies of ARFI imaging and SSI compared 
with transient elastography studies, although some studies showed 
that the performance and reliability of ARFI imaging and SSI are 
comparable to those of transient elastography [19,20,25]. According 
to a recent meta-analysis study for ARFI imaging, the mean 
diagnostic accuracy of ARFI expressed as areas under the receiver 
operating characteristic curves (AUROCs) was 0.87 for ≥F2, 0.93 
for ≥F3, and 0.93 for F4 [26]. In the case of real-time elastography, 
the elastic ratio (ratio of the value in the intrahepatic venous small 
vessels to the value in the parenchyma) was calculated instead of 
liver stiffness, and the diagnostic performance of this technique 
was superior to that of non-invasive biochemical markers including 
aspartate aminotransferase to the platelet ratio index (APRI) and the 
Forns Index [12].
consisting of an excitation application in which the examiner has to 
compress and relax the body by a transducer or utilize intrinsic stress 
derived from the heartbeat [12,13]. Simultaneously, echo signals are 
captured in real time, and the relative stiffness (elastic ratio) of the 
liver can be calculated along with a real-time color map. Like SSI, 
real-time tissue elastography can display tissue elasticity images and 
conventional grayscale US images at the same time but is unable to 
calculate the elastic modulus (Fig. 6).
Clinical Applications of US Elastography
Hepatic Fibrosis
In terms of the diagnostic performance of US elastography for 
measuring liver stiffness, there have been many clinical studies 
regarding the diagnosis of hepatic fibrosis using transient 
elastography [23,24]. According to a recent meta-analysis aimed 
at chronic hepatitis C patients, the pooled estimate of the cut-off 
value for significant fibrosis (≥F2 on the METAVIR score system) 
was 7.71 kPa with a sensitivity of 72% and specificity of 82%. In 
the case of cirrhosis (F4), the results showed a cut-off of 15.08 kPa 
with a sensitivity of 84% and specificity of 95%. Another meta-
Table 2. Summary sensitivity, specificity, and diagnostic odds ratio (DOR) to diagnose F2 and F4 fibrosis by using transient 
elastography extracted from a meta-analysis
Causes Stage Studies Cut-off liver stiffness Sensitivity (%) Specificity (%) DOR
Chronic hepatitis C ≥F2 14 07.6 (5.1-10.1) 78 (71-84) 80 (71-86) 13.9
F4 11 15.3 (11.9-26.5) 83 (77-88) 90 (87-93) 46.5
Chronic hepatitis B ≥F2 4 07.0 (6.9-7.2) 84 (67-93) 78 (68-85) 17.9
F4 6 11.3 (9.0-13.4) 80 (61-91) 89 (82-94) 34.3
Modified from Tsochatzis et al. [24]
Fig. 6. Real-time tissue elastography of 
the liver. The elastic ratio calculated from 
the tissue compressibility of the liver (A on 
the right) and that of the intrahepatic small 
vessel (B on the left) represents liver stiffness. 
On the look-up table, red and blue indicate 
soft and hard tissues, respectively. Reprinted 
from Koizumi et al. [12] with permission from 
the Radiological Society of North America.US elastography for diffuse liver disease
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The diagnostic performance of US elastography in patients with 
an HBV infection has not yet been well addressed. Marcellin et al. 
[27] first reported the diagnostic accuracy of transient elastography 
in the patients with chronic hepatitis B. Although the clinical 
evidence for fibrosis staging in patients with chronic hepatitis B is 
relatively weak and the overall diagnostic performance is slightly 
worse than for chronic hepatitis C patients, the diagnostic accuracy 
of transient elastography is acceptable [28]. In a recent meta-
analysis of the performance of transient elastography for the staging 
of liver fibrosis in chronic hepatitis B, the mean AUROCs for the 
diagnosis of significant fibrosis, severe fibrosis, and liver cirrhosis 
were 0.859, 0.887, and 0.929, respectively, as determined from 
18 studies comprising 2,772 patients [29]. Compared with HCV 
patients, the cut-off value for cirrhosis in HBV patients tends to be 
lower because the liver fibrosis area in macronodular cirrhosis is 
relatively smaller. In contrast, alanine aminotransferase flares can 
Fig. 7. Acute exacerbation of hepatitis B virus-induced hepatitis. 
Grayscale ultrasonography (A) shows mild parenchymal coarseness of the liver; the liver stiffness is 10.3 kPa according to the shear wave 
elastography (B). Six months later, the patients recovered from liver function deterioration. The grayscale ultrasonographic feature (C) is 
similar to the previous study, but the liver stiffness decreases to 6 kPa (D).
C D
A BWoo Kyoung Jeong, et al.
156   Ultrasonography 33(3), July 2014  e-ultrasonography.org
result in overestimating the fibrosis grade, and thus, the increased 
liver stiffness should be interpreted carefully in patients with acute 
exacerbation of chronic HBV hepatitis [30] (Fig. 7).
Non-Alcoholic Fatty Liver Disease  
Non-alcoholic fatty liver disease (NAFLD) actually represents an 
emerging disease of great clinical interest because of the increasing 
incidence of metabolic diseases and obesity in recent decades. 
The disease spectrum of NAFLD is very wide, ranging from simple 
fatty liver to non-alcoholic steatohepatitis, and liver fibrosis can 
develop and progress to liver cirrhosis [31]. Although transient 
elastography is difficult to perform in cases of obesity because 
subcutaneous fatty tissue attenuates the pushing pulse, its role 
in causing NAFLD has recently been highlighted owing to the 
development of a new technique utilizing a vibration-controlled 
transient elastography device, which allows the calculation of the 
new controlled attenuation parameter (CAP). CAP is known to be 
useful for the non-invasive and accurate estimation of liver steatosis 
[32]. In addition, a new XL probe designed to measure shear waves 
at deeper positions by using a lower central US frequency (2.5 
MHz) can be applied, thereby allowing more reliable results to be 
obtained compared with conventional M probes [33]. According 
to a diagnostic algorithm introduced by a recent review article 
[34], transient elastography could be useful to stratify patients 
at indeterminate risk; if liver stiffness was lower than 7.9 kPa, 
advanced fibrosis could be excluded with a 97% negative predictive 
value. On the other hand, if liver stiffness was higher than 9.6 kPa, 
the diagnosis of advanced fibrosis could be made with a 72% 
positive predictive value [35]. Thus, only the remaining patients 
(7.9-9.6 kPa) require liver biopsy for diagnosis, and the number of 
NAFLD patients with the indication of liver biopsy can be decreased, 
leading to a reduced incidence of biopsy-induced complications [34].
Follow-up after Liver Transplantation
After liver transplantation, US elastography is also useful to diagnose 
liver fibrosis caused by relapsed chronic hepatitis and the acute 
rejection of the liver graft. A systematic review of studies comparing 
US elastography to liver biopsy for the detection of liver fibrosis by 
a recurrent HCV infection stated that the diagnostic accuracy for 
significant fibrosis (F2) using transient elastography was generally 
good, with a sensitivity and a specificity of 83%. Further, with 
respect to liver cirrhosis, the sensitivity and specificity were improved 
to 98% and 84%, respectively [36]. Liver stiffness may also be 
increased by acute cellular rejection following liver transplantation; 
however, it is important to keep in mind that liver stiffness can 
increase in transplanted livers without evidence of rejection since 
it may undergo ischemic or reperfusion injury within 4 weeks from 
transplantation, which can in turn result in transient hepatocellular 
ballooning and hepatocanalicular cholestasis with inflammation that 
may recover within 2-3 weeks without specific treatment. Therefore, 
US elastography may be useful to detect rejection at follow-up more 
than 4 weeks after transplantation [37].
Portal Hypertension
Estimation of the severity of portal hypertension in patients with 
liver cirrhosis is another major use of liver stiffness measurements. 
Increased portal pressure is the major factor driving the clinical 
course of cirrhosis. Measurement of the hepatic venous pressure 
gradient (HVPG) following hepatic venous catheterization was used 
as a surrogate marker of portal hypertensive stigmata. Recently, 
there were some investigations concerning the feasibility of the 
noninvasive measurement of liver stiffness to estimate severe 
portal hypertension [38,39]. Looking at the results of these studies, 
we concluded that liver stiffness could be closely correlated with 
both HVPG and the presence of complications related with portal 
hypertension (Fig. 8).
Roles for Longitudinal Surveillance
To date, the majority of elastography studies have focused on 
evaluating the cross-sectional performance with respect to the 
histological fibrosis grade or HVPG. However, an important but 
undervalued use of elastography is the ability to repeatedly measure 
liver stiffness. The roles of elastography as longitudinal perspectives 
with respect to the prediction of the long-term prognosis of 
the disease and monitoring of clinical courses with or without 
treatment are well known. In particular, these approaches can be 
used to non-invasively estimate the prognosis of the patients with 
fatal complications related to CLD, such as variceal bleeding and 
decompensation.
A longitudinal follow-up of elastography has been proposed as a 
way to establish the tailored management strategies by providing 
more detailed prognostic information [40]. For example, the concept 
of cirrhosis has recently changed from dynamic to bidirectional. 
In other words, cirrhosis patients may recover if antiviral therapy 
can be applied properly. At this time, the ideal approach to assess 
histological outcomes during treatment is serial liver biopsy; however, 
this is not possible in most cases. Instead, the measurement of liver 
stiffness by elastography is very useful for monitoring the changes 
in liver fibrosis during the antiviral treatment [41,42]. In terms of 
portal hypertension, elastography may also be used to predict the 
development of variceal bleeding by using a hybrid parameter, the 
liver stiffness-spleen diameter to platelet ratio score (LSPS) defined 
as the product of liver stiffness and the maximum spleen diameter 
divided by the platelet count [43]. According to risk stratification US elastography for diffuse liver disease
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based on LSPS, a different prophylactic treatment for the prevention 
of variceal bleeding should be considered for patients with an LSPS 
value higher than 6.5 points [44].
US Elastography: Weaknesses and Strengths
The most significant challenge facing US elastography is the issue 
of measurement reproducibility. A number of studies concerning 
this issue have been published; however, many investigators have 
brought up questions about this issue due to the inherent limitations 
of US such as the operator-dependent performance. Transient 
elastography is a highly reproducible and user-friendly technique 
[45], and liver stiffness measurement by transient elastography does 
not require a learning curve: even a novice can obtain a reliable 
result after a single training session [46]. However, because liver 
stiffness measurements can be influenced significantly by steatosis, 
obesity, lower degrees of hepatic fibrosis [45], necroinflammation of 
hepatocytes [47], cholestasis [48], elevated central venous pressure 
[49], and even postprandial conditions [50], it should be carefully 
applied when used as an alternative measurement of liver stiffness 
instead of liver biopsy.
In the case of ARFI, the overall reproducibility is also not 
bad, having an intraclass correlation coefficient (ICC) value for 
the interrater observation of 0.81 and an ICC for the intrarater 
observation of 0.90. However, gender (women), high body mass 
index, ascites, and lower degree of liver disease (noncirrhotic 
patients) are considered factors that impede the reproducibility of 
ARFI [51]. In the case of SSI, the inter- and intraobserver agreements 
C
A
Fig. 8. Shear wave elastography of a patient with portal 
hypertension. 
On grayscale ultrasonography, the cirrhotic change of the liver and 
the perihepatic ascites (arrows) are noted (A). The measured liver 
stiffness is 42.6 kPa (B), which is about 8 times the normal value. 
The hepatic venous pressure gradient was 26.3 mmHg, which 
indicates severe portal hypertension (C).
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have ICC values of 0.88 and 0.94, respectively, which are similar to 
the results of ARFI imaging [52]. 
Despite the issues described above, US elastography has 
many advantages in clinical fields. The most important aspect is 
convenience, as is the case with most ultrasonography examination 
techniques. Indeed, US elastography is fast, easy to use, and 
portable, so much so that it can be performed at the patient’s 
bedside. Likewise, because it does not use ionizing radiation, US 
elastography is relatively safe, even in patients who repeatedly 
undergo the procedure. US elastography is also less expensive 
than MR elastography [53]. Going forward, the most important 
strength of US elastography is the availability of a large amount 
of accumulated clinical data that have demonstrated its clinical 
usefulness, although most of these data are related to transient 
elastography. 
Conclusions
Measurement of liver stiffness using various technical developments 
is evolving to overcome its limitations. Recently, the European 
Federation of Societies for Ultrasound in Medicine and Biology 
(EFSUMB) published an informative guideline for the use of US 
elastography [54,55] that deals with the relevant technology and 
clinical applications. Along with the basic principles for use, these 
guidelines include the practical advantages and disadvantages of 
US elastography as well as recommendations for the examination of 
various body parts. According to these guidelines, US elastography is 
useful to assess the severity of liver fibrosis in patients with diffuse 
liver disease and particularly to distinguish patients with nil to mild 
fibrosis from those with significant fibrosis, although some of the 
newer techniques must be validated through clinical studies. At 
present, however, US elastography for the differentiation of focal 
hepatic lesions is not recommended.
In conclusion, US elastography is useful for diagnosing hepatic 
fibrosis in patients with CLD and may be used as a convenient 
and non-invasive surveillance method to estimate the prognosis 
of patients with fatal complications related to CLD. Accordingly, 
the development of a standardized method for liver stiffness 
measurement and technical improvements should be a priority 
for the clinical application of US elastography. Together, these 
efforts will significantly enhance the clinical implications of US 
elastography.
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